Home/Filings/4/0001209191-21-054612
4//SEC Filing

Nall Michael W. 4

Accession 0001209191-21-054612

CIK 0001044378other

Filed

Sep 1, 8:00 PM ET

Accepted

Sep 2, 9:56 PM ET

Size

7.6 KB

Accession

0001209191-21-054612

Insider Transaction Report

Form 4
Period: 2021-09-02
Nall Michael W.
DirectorCEO AND PRESIDENT
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-09-02+100,000100,000 total
    Exercise: $3.76Exp: 2031-09-01Common Stock (100,000 underlying)
  • Award

    Performance-Based Employee Stock Option (right to buy)

    2021-09-02+80,00080,000 total
    Exercise: $3.76Exp: 2031-09-01Common Stock (80,000 underlying)
Footnotes (2)
  • [F1]1/36th of the shares subject to the option shall vest monthly following the Vesting Commencement Date of 9/2/21 until fully vested on 9/2/2024.
  • [F2]1/36th of the shares subject to the option shall vest monthly, commencing upon the Issuer's achievement of a specified corporate milestone.

Issuer

BIOCEPT INC

CIK 0001044378

Entity typeother

Related Parties

1
  • filerCIK 0001591849

Filing Metadata

Form type
4
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 9:56 PM ET
Size
7.6 KB